Genflow Biosciences PLC Announces Holding(s) in Company - 2

Rhea-AI Summary

Genflow Biosciences PLC (GENFF) has reported a significant change in shareholding. Jonathan Mark Swann from Rickmansworth, UK, has increased his voting rights in the company from 5.03% to 6.01%, representing 21,025,000 voting rights. The threshold was crossed on January 10, 2025, and the company was notified on January 13, 2025.

The notification indicates this change resulted from an acquisition of voting rights, with all shares being held directly. No financial instruments or similar economic instruments were reported as part of this holding. The shareholder is not controlled by any natural person or legal entity and does not control any other undertaking holding interests in Genflow Biosciences.

Positive

• Increased institutional ownership with single investor raising stake above 6%

Negative

• None.

News Market Reaction – GENFF

-0.50%

-0.50% Session move

In the trading session that priced this news, GENFF declined 0.50%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TR-1: Standard form for notification of major holdings

LONDON, UNITED KINGDOM / ACCESSWIRE / January 13, 2025 /

1. Issuer Details

ISIN

GB00BP2C3V08

Issuer Name

GENFLOW BIOSCIENCES PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Jonathan Mark Swann

City of registered office (if applicable)

rickmansworth

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

10-Jan-2025

6. Date on which Issuer notified

13-Jan-2025

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	6.010000	0.000000	6.010000	21025000
Position of previous notification (if applicable)	5.030000	0.000000	5.030000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BP2C3V08	21025000	0	6.010000	0.000000
Sub Total 8.A	21025000		6.010000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

none

12. Date of Completion

13-Jan-2025

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com .

SOURCE: Genflow Biosciences PLC

View the original press release on accesswire.com

FAQ

What is the new ownership percentage of Jonathan Swann in GENFF as of January 2025?

Jonathan Mark Swann's ownership in Genflow Biosciences (GENFF) increased to 6.01% of voting rights, representing 21,025,000 shares, as of January 10, 2025.

How much did Jonathan Swann's ownership in GENFF increase from the previous position?

Jonathan Swann's ownership increased from 5.03% to 6.01%, representing an increase of 0.98 percentage points in voting rights.

When did GENFF report this change in shareholding?

Genflow Biosciences reported the change in shareholding on January 13, 2025, three days after the threshold was crossed on January 10, 2025.

Does Jonathan Swann hold any financial instruments in GENFF besides direct shares?

No, according to the notification, Jonathan Swann holds only direct voting rights and no additional financial instruments or instruments with similar economic effect.